Presentation is loading. Please wait.

Presentation is loading. Please wait.

Focal Peripheral Neuropathies Dr Jeremy Bland British Peripheral Nerve Society Charing Cross Hospital, 18 th October 2013.

Similar presentations


Presentation on theme: "Focal Peripheral Neuropathies Dr Jeremy Bland British Peripheral Nerve Society Charing Cross Hospital, 18 th October 2013."— Presentation transcript:

1 Focal Peripheral Neuropathies Dr Jeremy Bland British Peripheral Nerve Society Charing Cross Hospital, 18 th October 2013

2 Frequencies of referral in Canterbury

3 Latinovic/Hughes 2006

4 Plan CTS - COMMON Investigation Treatment Ulnar neuropathy - Common Investigation Treatment Peroneal neuropathy – We are not sure what to do with it! Causes Treatment TTS – Rare to non-existent but talked about a lot! Existence! Quality of evidence HLPP – Just interesting for the BPNS

5 For Each Topic Survey results 12 Neurology, 22 Neurophysiology, 2 Other Numbers do not always add up Missing answers Multiple answers Where it seems to be interesting Neurology vs Neurophysiology Something thought provoking Discussion

6 CTS – Investigation with NCS

7 Why bother? – Choosing a treatment?

8 CTS – Investigation with u/s Use or recommend ultrasound Neurology 3 Neurophysiology 7 Other 1

9 Sensitivity vs clinical diagnosis 81 patients with right hand symptoms and symptom score > 0.8 – classical CTS – NCS sensitivity = 98%, u/s sensitivity = 81%

10 CTS – Management- Inject

11 Injections per hand Canterbury CTS clinic 5927 injections 5 serious complications

12 Ulnar – Investigation- NCS Investigate when suspected: Neurology 75% Neurophysiology 91% cf CTS – 27%

13 Uncertainties Sensitivity 37-86% (cf imaging 80-90%?) Accuracy of localisation 80% (compared to intra-operative studies) No demonstrably useful severity grading Padua classification not verified to be: Sensitive to change Prognostic

14 Ulnar – Management 73% neurophysiologists would go with surgery for persistent symptoms only 60% neurologists would wait for physical signs or evidence or progression

15 Ulnar Neuropathy at the elbow Beekman, R et al, 2004, Ulnar neuropathy at the elbow: follow-up and prognostic factors determining outcome, Neurology 63:1675-80 Non-prognostic clinical variables Age Sex Symptom duration Dominant arm Muscle weakness MRC sum score Muscle atrophy

16 Ulnar Prognosis (Beekman) No patient with an ulnar nerve diameter >3.5 mm improved on follow up whether treated surgically or not

17 Peroneal – Ganglion Cysts 6 people have come across these 1 neurologist, 5 neurophysiologists One person has seen 3 and one 2

18 Patient PH, Peroneal nerve

19 Peroneal – Management Very little consensus Only 1 person would suggest surgery for persistent symptoms only 10 Neurophysiologists would consider a demonstrable NCS abnormality an indication for surgery 3 people said never operate! 16 people declared ‘other criteria’ but no-one explained exactly what!

20 Tarsal Tunnel – quality of proof Hx consistent NCS abnormal Imaging abnormal Operated Got better NCS better

21 Cases PTN GC

22 HLPP

23 Sander et al, J Hand Surg, 2005; 30A 6 59 patients >1 CTR and/or ulnar transposition 0 cases HLPP Only 7 with 3 operations 14 with a Hx of an entrapment neuropathy in a 1 st degree relative

24 What else? Have you changed your mind about anything or will you alter practice in any way as a result of this session? Should we try to do a more definitive questionnaire? Should we revisit the topic (with questionnaires collected today or a new one or both) at a future BPNS meeting


Download ppt "Focal Peripheral Neuropathies Dr Jeremy Bland British Peripheral Nerve Society Charing Cross Hospital, 18 th October 2013."

Similar presentations


Ads by Google